Form 4: Moderna CFO James Mock Reports Stock Transactions

Chief Financial Officer of Moderna, James Mock, reports acquisition and disposal of Moderna shares related to restricted stock units.

Summary

• James Mock, the Chief Financial Officer of Moderna, reported transactions involving Moderna's common stock.
• On May 24, 2024, Mock acquired 6,374 shares upon the conversion of 1,326 restricted stock units (RSUs) and disposed of 1,326 shares.
• On May 28, 2024, Mock disposed of 648 shares at a price of $162.4736 to cover tax withholding obligations related to the vesting of RSUs.
• Following these transactions, Mock beneficially owns 5,726 shares of Moderna common stock and 3,978 restricted stock units.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing related to executive stock transactions, indicating a neutral sentiment.

Industry Context

This filing is a routine disclosure of stock transactions by a company executive, which is common in publicly traded companies. It provides transparency to investors regarding insider activity.

Comparison to Industry Standards

• Executive stock transactions are a normal part of compensation packages in publicly traded companies like Moderna.
• Companies such as Pfizer, BioNTech, and Johnson & Johnson also have similar reporting requirements for their executives' stock transactions.
• The 'sell to cover' mechanism for tax obligations is a standard practice across the industry.

Stakeholder Impact

• The transactions provide transparency to shareholders regarding executive compensation and stock ownership.
• The 'sell to cover' mechanism ensures compliance with tax obligations.

Key Dates